Pacific Biosciences Of California (PACB) Other financing activities (2018 - 2023)

Pacific Biosciences Of California has reported Other financing activities for 6 years, with the latest figure at $50000.0 in Q4 2023.

• For the quarter ending Q4 2023, Other financing activities changed N/A year-over-year to $50000.0; the trailing twelve-month figure through Dec 2024 stood at $539000.0 (down 86.8% YoY), and the FY2023 full-year result was $7.4 million, changed N/A from the prior year.
• Other financing activities for Q4 2023 stood at $50000.0, down from $489000.0 in the prior quarter.
• The five-year high for Other financing activities was $32.2 million in Q4 2020, with the low at $50000.0 in Q4 2023.
• Average Other financing activities over 5 years is $5.7 million, with a median of $1.4 million recorded in 2019.
• Year-over-year, Other financing activities soared 24469.47% in 2020 and plunged 99.24% in 2021.
• Tracing PACB's Other financing activities over 5 years: stood at $131000.0 in 2019, then soared by 24469.47% to $32.2 million in 2020, then sank by 99.24% to $246000.0 in 2021, then jumped by 1340.24% to $3.5 million in 2022, then plunged by 98.59% to $50000.0 in 2023.
• The last three Other financing activities figures came in at $50000.0 (Q4 2023), $489000.0 (Q3 2023), and $3.5 million (Q3 2022), per Business Quant data.

Peer Comparison